XML 65 R53.htm IDEA: XBRL DOCUMENT v3.22.1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The following table reconciles the numerator and denominator in computing the Company’s basic and diluted earnings per share to net (loss) income available to common stockholders:
Three Months Ended March 31,
20222021
Numerator:
Basic and diluted net (loss) income available to common stockholders
$(19,793)$4,982 
Denominator:
Basic weighted average common shares outstanding149,187,994 150,823,605 
Effect of dilutive instruments(1)(2)
— 317,474 
DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING149,187,994 151,141,079 
Basic earnings per common share$(0.13)$0.03 
Diluted earnings per common share$(0.13)$0.03 
________________
1.The Company includes unvested awards and convertible common and participating units as contingently issuable shares in the computation of diluted earnings per share once the market or performance criteria are met, assuming that the end of the reporting period is the end of the contingency period. Any anti-dilutive securities are excluded from the diluted earnings per share calculation.
2.The Company includes the dilutive effect of the forward sale component of its accelerated share repurchase agreements in the computation of diluted earnings per share.
The following table reconciles the numerator and denominator in computing the operating partnership’s basic and diluted earnings per unit to net (loss) income available to common unitholders:
Three Months Ended March 31,
20222021
Numerator:
Basic and diluted net (loss) income available to common unitholders$(20,023)$5,032 
Denominator:
Basic weighted average common units outstanding151,031,790 152,186,394 
Effect of dilutive instruments(1)(2)
— 317,474 
DILUTED WEIGHTED AVERAGE COMMON UNITS OUTSTANDING151,031,790 152,503,868 
Basic earnings per common unit$(0.13)$0.03 
Diluted earnings per common unit$(0.13)$0.03 
________________
1.The operating partnership includes unvested awards as contingently issuable units in the computation of diluted earnings per unit once the market or performance criteria are met, assuming that the end of the reporting period is the end of the contingency period. Any anti-dilutive securities are excluded from the diluted earnings per unit calculation.
2.The Company includes the dilutive effect of the forward sale component of its accelerated share repurchase agreements in the computation of diluted earnings per share.